Autologous blood transfusion with ropivacaine — Competitive Intelligence Brief

Autologous blood transfusion with ropivacaine (Autologous blood transfusion with ropivacaine) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Local anesthetic. Area: Anesthesiology.

phase 2 Local anesthetic Anesthesiology Small molecule

Target snapshot

Autologous blood transfusion with ropivacaine (Autologous blood transfusion with ropivacaine) — Northern Orthopaedic Division, Denmark. Autologous blood transfusion with ropivacaine involves reinfusing a patient's own blood that has been collected and treated with ropivacaine to reduce pain.

Comparator set (6 drugs)

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
Autologous blood transfusion with ropivacaine TARGET	Autologous blood transfusion with ropivacaine	Northern Orthopaedic Division, Denmark	phase 2	Local anesthetic
Tetracaine Hydrochloride	TETRACAINE	Alcon Labs	marketed	Ester Local Anesthetic	Sodium channel protein type 7 subunit alpha	2005-01-01
Septocaine	ARTICAINE		marketed	Amide Local Anesthetic	Sodium channel alpha subunits; brain (Types I, II, III)	2000-01-01
Naropin	ROPIVACAINE	Fresenius Kabi	marketed	Amide Local Anesthetic	Sodium channel protein type 5 subunit alpha	1996-01-01
Bupivacaine Hydrochloride And Epinephrine	BUPIVACAINE	Innocoll	marketed	Amide Local Anesthetic	Cytochrome P450 2D6	1972-01-01
Bupivacaine Hydrochloride And Epinephrine	Bupivacaine Hydrochloride	Pfizer	marketed	Local anesthetic	Sodium channels	1972-01-01
Bupivacaine Hydrochloride And Epinephrine	Bupivacaine Hydrochloride	Pfizer	marketed	Amide local anesthetic	Nerve sodium channels	1972-01-01

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Local anesthetic class)

1. University of California, San Diego · 3 drugs in this class
2. Durect · 3 drugs in this class
3. Pacira Pharmaceuticals, Inc · 3 drugs in this class
4. Wake Forest University Health Sciences · 3 drugs in this class
5. Medical University of Vienna · 3 drugs in this class
6. Imperial College London · 2 drugs in this class
7. Hvidovre University Hospital · 2 drugs in this class
8. Innocoll · 2 drugs in this class
9. George Washington University · 2 drugs in this class
10. Guy's and St Thomas' NHS Foundation Trust · 2 drugs in this class